US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist

8.130
+0.460+6.00%

Trading Nov 29 09:35 ET

383.86MMarket Cap-4768P/E (TTM)

Silence Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-59.19%1.14M

-93.43%598K

9.07%12.41M

44.99%25.38M

-55.95%2.1M

-17.00%2.8M

149.90%9.1M

98.78%11.37M

40.97%17.5M

39.57%4.77M

Operating revenue

-59.19%1.14M

-93.43%598K

9.07%12.41M

44.99%25.38M

-55.95%2.1M

-17.00%2.8M

149.90%9.1M

98.78%11.37M

40.97%17.5M

39.57%4.77M

Cost of revenue

72.62%2.77M

-6.82%2.64M

-51.19%2.21M

-5.17%10.32M

-65.12%1.35M

-32.87%1.61M

20.37%2.83M

99.30%4.53M

45.92%10.88M

88.98%3.86M

Gross profit

-237.03%-1.63M

-132.52%-2.04M

49.02%10.19M

127.41%15.06M

-16.89%753K

21.90%1.19M

385.90%6.27M

98.43%6.84M

33.51%6.62M

-33.97%906K

Operating expense

50.50%20.91M

-8.16%16.28M

-24.44%14.35M

17.11%64.66M

18.41%14.05M

-4.85%13.89M

15.28%17.73M

42.04%18.99M

8.75%55.21M

-6.08%11.87M

Selling and administrative expenses

12.99%5.6M

3.38%5.29M

-19.84%5.17M

5.24%20.64M

18.66%4.12M

-14.95%4.96M

12.47%5.12M

11.86%6.45M

-1.99%19.61M

-35.91%3.47M

-General and administrative expense

12.99%5.6M

3.38%5.29M

-19.84%5.17M

5.24%20.64M

18.66%4.12M

-14.95%4.96M

12.47%5.12M

11.86%6.45M

-1.99%19.61M

-35.91%3.47M

Research and development costs

71.31%15.31M

-12.84%11M

-26.80%9.18M

23.65%44.03M

18.31%9.94M

1.86%8.93M

16.46%12.62M

64.92%12.54M

15.73%35.61M

16.27%8.4M

Operating profit

-77.47%-22.54M

-59.93%-18.32M

65.79%-4.16M

-2.08%-49.6M

-21.33%-13.3M

6.77%-12.7M

18.68%-11.46M

-22.45%-12.15M

-6.07%-48.59M

2.68%-10.96M

Net non-operating interest income expense

-473.95%-7.62M

259.49%882K

250.95%791K

688.83%1.41M

108.78%451K

-52.55%2.04M

-182.66%-553K

-249.71%-524K

8,850.00%179K

-6,518.75%-5.14M

Non-operating interest income

-52.05%981K

213.24%1.07M

139.29%804K

539.82%1.45M

107.58%388K

-52.74%2.05M

-49.18%340K

-4.00%336K

2,160.00%226K

-256,200.00%-5.12M

Non-operating interest expense

107,425.00%8.6M

-79.51%183K

-98.49%13K

-27.66%34K

-584.62%-63K

-76.47%8K

--893K

--860K

487.50%47K

116.67%13K

Other net income (expense)

-302.49%-2.12M

2,477.27%1.05M

Gain on sale of security

----

-302.49%-2.12M

----

2,477.27%1.05M

----

Income before tax

-182.88%-30.16M

-45.22%-17.44M

73.45%-3.37M

-6.21%-50.31M

0.56%-14.97M

-14.31%-10.66M

10.51%-12.01M

-32.40%-12.67M

-3.30%-47.37M

-34.05%-15.05M

Income tax

-30.49%-3.15M

-16.78%-1.88M

39.69%-1.49M

-2.38%-7.04M

56.95%-554K

-8.46%-2.41M

-8.64%-1.61M

-30.77%-2.47M

-6.72%-6.88M

28.22%-1.29M

Net income

-227.42%-27.01M

-49.62%-15.56M

81.62%-1.88M

-6.86%-43.27M

-4.72%-14.41M

-16.15%-8.25M

12.88%-10.4M

-32.80%-10.2M

-2.74%-40.49M

-45.89%-13.76M

Net income continuous Operations

-227.42%-27.01M

-49.62%-15.56M

81.62%-1.88M

-6.86%-43.27M

-4.72%-14.41M

-16.15%-8.25M

12.88%-10.4M

-32.80%-10.2M

-2.74%-40.49M

-45.89%-13.76M

Minority interest income

Net income attributable to the parent company

-227.42%-27.01M

-49.62%-15.56M

81.62%-1.88M

-6.86%-43.27M

-4.72%-14.41M

-16.15%-8.25M

12.88%-10.4M

-32.80%-10.2M

-2.74%-40.49M

-45.89%-13.76M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-227.42%-27.01M

-49.62%-15.56M

81.62%-1.88M

-6.86%-43.27M

-4.72%-14.41M

-16.15%-8.25M

12.88%-10.4M

-32.80%-10.2M

-2.74%-40.49M

-45.89%-13.76M

Basic earnings per share

-158.11%-0.573

-15.63%-0.333

85.26%-0.042

7.16%-1.167

4.58%-0.375

-2.78%-0.222

27.82%-0.288

-10.47%-0.285

5.42%-1.257

-24.76%-0.393

Diluted earnings per share

-158.11%-0.573

-15.63%-0.333

85.26%-0.042

7.16%-1.167

4.58%-0.375

-2.78%-0.222

27.82%-0.288

-10.47%-0.285

5.42%-1.257

-24.76%-0.393

Dividend per share

Currency Unit

GBP

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-59.19%1.14M	-93.43%598K	9.07%12.41M	44.99%25.38M	-55.95%2.1M	-17.00%2.8M	149.90%9.1M	98.78%11.37M	40.97%17.5M	39.57%4.77M
Operating revenue	-59.19%1.14M	-93.43%598K	9.07%12.41M	44.99%25.38M	-55.95%2.1M	-17.00%2.8M	149.90%9.1M	98.78%11.37M	40.97%17.5M	39.57%4.77M
Cost of revenue	72.62%2.77M	-6.82%2.64M	-51.19%2.21M	-5.17%10.32M	-65.12%1.35M	-32.87%1.61M	20.37%2.83M	99.30%4.53M	45.92%10.88M	88.98%3.86M
Gross profit	-237.03%-1.63M	-132.52%-2.04M	49.02%10.19M	127.41%15.06M	-16.89%753K	21.90%1.19M	385.90%6.27M	98.43%6.84M	33.51%6.62M	-33.97%906K
Operating expense	50.50%20.91M	-8.16%16.28M	-24.44%14.35M	17.11%64.66M	18.41%14.05M	-4.85%13.89M	15.28%17.73M	42.04%18.99M	8.75%55.21M	-6.08%11.87M
Selling and administrative expenses	12.99%5.6M	3.38%5.29M	-19.84%5.17M	5.24%20.64M	18.66%4.12M	-14.95%4.96M	12.47%5.12M	11.86%6.45M	-1.99%19.61M	-35.91%3.47M
-General and administrative expense	12.99%5.6M	3.38%5.29M	-19.84%5.17M	5.24%20.64M	18.66%4.12M	-14.95%4.96M	12.47%5.12M	11.86%6.45M	-1.99%19.61M	-35.91%3.47M
Research and development costs	71.31%15.31M	-12.84%11M	-26.80%9.18M	23.65%44.03M	18.31%9.94M	1.86%8.93M	16.46%12.62M	64.92%12.54M	15.73%35.61M	16.27%8.4M
Operating profit	-77.47%-22.54M	-59.93%-18.32M	65.79%-4.16M	-2.08%-49.6M	-21.33%-13.3M	6.77%-12.7M	18.68%-11.46M	-22.45%-12.15M	-6.07%-48.59M	2.68%-10.96M
Net non-operating interest income expense	-473.95%-7.62M	259.49%882K	250.95%791K	688.83%1.41M	108.78%451K	-52.55%2.04M	-182.66%-553K	-249.71%-524K	8,850.00%179K	-6,518.75%-5.14M
Non-operating interest income	-52.05%981K	213.24%1.07M	139.29%804K	539.82%1.45M	107.58%388K	-52.74%2.05M	-49.18%340K	-4.00%336K	2,160.00%226K	-256,200.00%-5.12M
Non-operating interest expense	107,425.00%8.6M	-79.51%183K	-98.49%13K	-27.66%34K	-584.62%-63K	-76.47%8K	--893K	--860K	487.50%47K	116.67%13K
Other net income (expense)				-302.49%-2.12M					2,477.27%1.05M
Gain on sale of security	----	----	----	-302.49%-2.12M	----	----	----	----	2,477.27%1.05M	----
Income before tax	-182.88%-30.16M	-45.22%-17.44M	73.45%-3.37M	-6.21%-50.31M	0.56%-14.97M	-14.31%-10.66M	10.51%-12.01M	-32.40%-12.67M	-3.30%-47.37M	-34.05%-15.05M
Income tax	-30.49%-3.15M	-16.78%-1.88M	39.69%-1.49M	-2.38%-7.04M	56.95%-554K	-8.46%-2.41M	-8.64%-1.61M	-30.77%-2.47M	-6.72%-6.88M	28.22%-1.29M
Net income	-227.42%-27.01M	-49.62%-15.56M	81.62%-1.88M	-6.86%-43.27M	-4.72%-14.41M	-16.15%-8.25M	12.88%-10.4M	-32.80%-10.2M	-2.74%-40.49M	-45.89%-13.76M
Net income continuous Operations	-227.42%-27.01M	-49.62%-15.56M	81.62%-1.88M	-6.86%-43.27M	-4.72%-14.41M	-16.15%-8.25M	12.88%-10.4M	-32.80%-10.2M	-2.74%-40.49M	-45.89%-13.76M
Minority interest income
Net income attributable to the parent company	-227.42%-27.01M	-49.62%-15.56M	81.62%-1.88M	-6.86%-43.27M	-4.72%-14.41M	-16.15%-8.25M	12.88%-10.4M	-32.80%-10.2M	-2.74%-40.49M	-45.89%-13.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-227.42%-27.01M	-49.62%-15.56M	81.62%-1.88M	-6.86%-43.27M	-4.72%-14.41M	-16.15%-8.25M	12.88%-10.4M	-32.80%-10.2M	-2.74%-40.49M	-45.89%-13.76M
Basic earnings per share	-158.11%-0.573	-15.63%-0.333	85.26%-0.042	7.16%-1.167	4.58%-0.375	-2.78%-0.222	27.82%-0.288	-10.47%-0.285	5.42%-1.257	-24.76%-0.393
Diluted earnings per share	-158.11%-0.573	-15.63%-0.333	85.26%-0.042	7.16%-1.167	4.58%-0.375	-2.78%-0.222	27.82%-0.288	-10.47%-0.285	5.42%-1.257	-24.76%-0.393
Dividend per share
Currency Unit	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data